E
RAIN

Ergoteles’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Ergoteles’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-65,096
Closed -$318K – 2027
2022
Q3 		$318K Sell
65,096
-5,604
-8% -$35.2K 0.01% 952
2022
Q2 		$393K Buy
+70,700
New +$243K 0.01% 965

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ergoteles's RAIN Position: Q4 2022 in Review

Ergoteles sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2022, closing a stake of 65,096 shares — an estimated $318K sold.

Ergoteles first reported a position in RAIN in Q2 2022 and held it in 2 quarters. The position peaked at $393K in Q2 2022. 46 funds tracked by Wall St. Rank hold RAIN as of Q4 2022.

  • Ergoteles reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 65,096 Rain Oncology Inc. Common Stock shares in Q4 2022, an estimated $318K.
  • Ergoteles first reported a position in Rain Oncology Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Ergoteles's Rain Oncology Inc. Common Stock position peaked at $393K in Q2 2022.
  • 46 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.